Emerging Health IssuesLegal Actions/Court DecisionsPart D/Prescription Drugs

Ohio’s board of pharmacy bans hydroxychloroquine for use in COVID-19 patients

(By Maia Anderson for Becker’s Hospital Review)

Ohio’s board of pharmacy has banned hydroxychloroquine as a COVID-19 treatment.

As of July 30, pharmacists are prohibited from dispensing or selling the drug to treat COVID-19. Any pharmacist found to be selling or dispensing the drug for COVID-19 purposes could face disciplinary action ranging from a warning or fine to temporary suspension of their license, The Columbus Dispatch reported.   Continue reading article here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org


Leave a Reply